{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.4","value":"34.8"},{"groupId":"OG001","spread":"1.5","value":"34.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"20"}],"units":"Participants"}],"title":"Baseline - Stress management"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.8","value":"33.1"},{"groupId":"OG001","spread":"1.8","value":"30.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"20"}],"units":"Participants"}],"title":"Baseline - Coping with treatment-related side effects"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.3","value":"37.8"},{"groupId":"OG001","spread":"0.9","value":"39.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"20"}],"units":"Participants"}],"title":"Baseline - Accepting cancer/maintaining positive attitude"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.6","value":"28.2"},{"groupId":"OG001","spread":"1.6","value":"29.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"20"}],"units":"Participants"}],"title":"Baseline - Affective regulation"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.3","value":"38.1"},{"groupId":"OG001","spread":"1.9","value":"38.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"title":"8 weeks - Stress management"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.7","value":"37.1"},{"groupId":"OG001","spread":"2.1","value":"35.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"title":"8 weeks - Coping with treatment-related side effects"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.2","value":"40.4"},{"groupId":"OG001","spread":"1.6","value":"38.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"title":"8 weeks - Accepting cancer/maintaining positive attitude"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.1","value":"29.8"},{"groupId":"OG001","spread":"2.1","value":"31.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"title":"8 weeks - Affective regulation"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.1","value":"38.2"},{"groupId":"OG001","spread":"1.6","value":"38.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"title":"10 weeks - Stress management"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.6","value":"36.8"},{"groupId":"OG001","spread":"2.3","value":"37.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"title":"10 weeks - Coping with treatment-related side effects"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.9","value":"40.6"},{"groupId":"OG001","spread":"1.6","value":"40.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"title":"10 weeks - Accepting cancer/maintaining positive attitude"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.2","value":"30.1"},{"groupId":"OG001","spread":"2.3","value":"33.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"title":"10 weeks - Affective regulation"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.4","value":"39.2"},{"groupId":"OG001","spread":"1.1","value":"40.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"title":"14 weeks - Stress management"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.7","value":"37.0"},{"groupId":"OG001","spread":"1.5","value":"38.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"title":"14 weeks - Coping with treatment-related side effects"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.2","value":"40.0"},{"groupId":"OG001","spread":"1.0","value":"41.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"title":"14 weeks - Accepting cancer/maintaining positive attitude"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.1","value":"32.3"},{"groupId":"OG001","spread":"1.9","value":"34.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"title":"14 weeks - Affective regulation"}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"20"}],"units":"Participants"}],"description":"Regulation of psychological stress will be determined by ratings on four of the seven factors of the Cancer Behavior Inventory, which assess self-efficacy for stress management, coping with treatment-related side-effects, accepting cancer/maintaining positive attitude, and affective regulation. Scale ranged from 1-9 (1 - 3 not at all confident; 4-6 moderately confident and 7-9 totally confident). 4 of the 7 items from the Cancer Behavior Inventory (V2.0) were used with each item's score ranges from 0-50 with higher scores indicating more confidence in the item.","dispersionType":"Standard Error","groups":[{"description":"Patients participate in YST consisting of four 30 minute in-person yoga sessions at weeks 2, 4, 6, and 8 that instructs skills to enhance mindfulness and promote relaxation, through instruction of awareness, movement, breathing practices, and meditation.\n\nLaboratory Biomarker Analysis: Correlative studies\n\nQuestionnaire Administration: Ancillary studies\n\nDaily Survey Administration: Ancillary studies\n\nYoga Skills Training: The YST intervention consists of four 30 minute in-person sessions that instructs skills to enhance mindfulness and promote relaxation. Participants will also be encouraged to practice daily at home.\n\nActigraphy Assessment: Ancillary studies","id":"OG000","title":"Group I (Yoga Skills Training)"},{"description":"Patients participate in four 30 minute in-person sessions of supportive conversation at weeks 2, 4, 6, 8.\n\nLaboratory Biomarker Analysis: Correlative studies\n\nQuestionnaire Administration: Ancillary studies\n\nDaily Survey Administration: Ancillary studies\n\nAttention Control: The AC intervention consists of four 30 minute in-person sessions of supportive conversation. In addition, the interventionist will recommend that the patients write brief diary entries daily at home.\n\nActigraphy Assessment: Ancillary studies","id":"OG001","title":"Group II (Attention Control)"}],"paramType":"MEAN","populationDescription":"Numbers may vary based on number of participants that actually completed intervention materials","reportingStatus":"POSTED","timeFrame":"At baseline, 8 weeks, 10 weeks and 14 weeks after start of intervention","title":"Regulation of Psychological Stress Assessed Using the Cancer Behavior Inventory","type":"SECONDARY","unitOfMeasure":"score on a scale"}